Page last updated: 2024-09-03

prolame and No-Reflow Phenomenon

prolame has been researched along with No-Reflow Phenomenon in 1 studies

*No-Reflow Phenomenon: Markedly reduced or absent REPERFUSION in an infarct zone following the removal of an obstruction or constriction of an artery. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Coral-Vázquez, RM; de la Peña, A; De Los Santos, S; Fernández-G, JM; Flores, M; Flores, PL; Hernández-Reséndiz, S; Palma-Flores, C; Román-Anguiano, NG; Zazueta, C1

Other Studies

1 other study(ies) available for prolame and No-Reflow Phenomenon

ArticleYear
Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade.
    Basic research in cardiology, 2015, Volume: 110, Issue:2

    Topics: Animals; Blotting, Western; Disease Models, Animal; Endothelial Cells; Estrenes; Hemodynamics; Humans; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Nitric Oxide Synthase Type III; No-Reflow Phenomenon; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Umbilical Veins

2015